International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension

Journal of the American College of Cardiology

Volumn 62, Issue 22, 2013, Pages 2031-2045

  Schlaich, Markus P ^a   Schmieder, Roland E ^b   Bakris, George ^c   Blankestijn, Peter J ^d   Böhm, Michael ^e   Campese, Vito M ^f   Francis, Darrel P ^g   Grassi, Guido ^h   Hering, Dagmara ^a   Katholi, Richard ⁱ   Kjeldsen, Sverre ^j   Krum, Henry ^a   Mahfoud, Felix ^e   Mancia, Giuseppe ^h   Messerli, Franz H ^k   Narkiewicz, Krzysztof ^l   Parati, Gianfranco ^h,m   Rocha Singh, Krishna J ⁱ   Ruilope, Luis M ⁿ   Rump, Lars C ^o   Sica, Domenic A ^p   Sobotka, Paul A ^q   Tsioufis, Costas ^r   Vonend, Oliver ^o   Weber, Michael A ^s   Williams, Bryan ^t   Zeller, Thomas ^u   Esler, Murray D ^a   more..

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e SAARLAND UNIVERSITY   (Germany)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ Prairie Education and Research Cooperative   (United States)

^j UNIVERSITY OF OSLO   (Norway)

^k Och Spine at New York Presbyterian Hospitals   (United States)

^l MEDICAL UNIVERSITY OF GDANSK   (Poland)

^m ISTITUTO AUXOLOGICO ITALIANO   (Italy)

ⁿ HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^o HEINRICH HEINE UNIVERSITY   (Germany)

^p VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r UNIVERSITY OF ATHENS   (Greece)

^s SUNY Downstate Medical Center   (United States)

^t UNIVERSITY COLLEGE LONDON   (United Kingdom)

^u Heart Centre Bad Krozingen   (Germany)

more..

Author keywords

renal denervation; resistant hypertension; sympathetic

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; CATHETER ABLATION; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DENERVATION; KIDNEY FAILURE; NONHUMAN; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL RENAL DENERVATION; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT;

EID: 84888387621     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.1616     Document Type: Review

References (63)

1. G. Mancia, G. De Backer, and A. Dominiczak 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187
2. S.D. Persell Prevalence of resistant hypertension in the United States 2003-2008 Hypertension 57 2011 1076 1080
3. A. de la Sierra, J. Segura, and J.R. Banegas Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
4. S.L. Daugherty, J.D. Powers, and D.J. Magid Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
5. E. Pimenta, and D.A. Calhoun Resistant hypertension: incidence, prevalence, and prognosis Circulation 125 2012 1594 1596
6. M. Esler, G. Jennings, G. Lambert, I. Meredith, M. Horne, and G. Eisenhofer Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions Physiol Rev 70 1990 963 985
7. G. Parati, and M. Esler The human sympathetic nervous system: its relevance in hypertension and heart failure Eur Heart J 33 2012 1058 1066
8. R.E. Katholi, P.L. Whitlow, G.R. Hageman, and W.T. Woods Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog J Hypertens 2 1984 349 359
9. S. Ye, B. Ozgur, and V.M. Campese Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure Kidney Int 51 1997 722 727
10. U.C. Kopp, M.Z. Cicha, L.A. Smith, J. Mulder, and T. Hokfelt Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers Am J Physiol Regul Integr Comp Physiol 293 2007 R1561 R1572
11. V.M. Campese, and E. Kogosov Renal afferent denervation prevents hypertension in rats with chronic renal failure Hypertension 25 1995 878 882
12. G.F. DiBona Physiology in perspective: the wisdom of the body. Neural control of the kidney Am J Physiol Regul Integr Comp Physiol 289 2005 R633 R641
13. M.P. Schlaich, E. Lambert, and D.M. Kaye Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation Hypertension 43 2004 169 175
14. M.P. Schlaich, D.M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M.D. Esler Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 2003 560 565
15. H. Krum, M. Schlaich, and R. Whitbourn Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
16. K. Steigerwald, A. Titova, and C. Malle Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model J Hypertens 30 2012 2230 2239
17. ® catheter system and the EnligHTN multi-electrode renal denervation catheter Eur Heart J 34 2013 2141 2148
18. F. Mahfoud, T.F. Luscher, and B. Andersson Expert consensus document from the European Society of Cardiology on catheter-based renal denervation Eur Heart J 34 2013 2149 2157
19. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 2009 932 934
20. D. Hering, E.A. Lambert, and P. Marusic Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension Hypertension 61 2013 457 464
21. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial Lancet 376 2010 1903 1909
22. M.D. Esler, H. Krum, M. Schlaich, R.E. Schmieder, M. Bohm, and P.A. Sobotka Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial Circulation 126 2012 2976 2982
23. D.E. Kandzari, D.L. Bhatt, and P.A. Sobotka Catheter-based renal denervation for resistant hypertension: rationale and design of the Symplicity HTN-3 trial Clin Cardiol 35 2012 528 535
24. A. Persu, Y. Jin, and M. Monge Renal denervation in resistant hypertension: experience at 8 leading European Hypertension Centres J Hypertens 31 suppl 2013 e47 e48
25. F.E. Fadl Elmula, P. Hoffmann, and E. Fossum Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure Hypertension 62 2013 526 532
26. F. Mahfoud, C. Ukena, and R.E. Schmieder Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension Circulation 128 2013 132 140
27. C. Ott, F. Mahfoud, and A. Schmid Renal denervation in moderate treatment resistant hypertension J Am Coll Cardiol 62 2013 1880 1886
28. B. Kaltenbach, J. Franke, S.C. Bertog, D.H. Steinberg, I. Hofmann, and H. Sievert Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study Catheter Cardiovasc Interv 81 2013 335 339
29. J. Brinkmann, K. Heusser, and B.M. Schmidt Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series Hypertension 60 2012 1485 1490
30. G. Parati, J.E. Ochoa, and G. Bilo Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity? Circulation 128 2013 315 317
31. Symplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months Hypertension 57 2011 911 917
32. O. Vonend, G. Antoch, L.C. Rump, and D. Blondin Secondary rise in blood pressure after renal denervation Lancet 380 2012 778
33. B. Kaltenbach, D. Id, and J.C. Franke Renal artery stenosis after renal sympathetic denervation J Am Coll Cardiol 60 2012 2694 2695
34. C. Ukena, F. Mahfoud, and A. Spies Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension Int J Cardiol 167 2013 2846 2851
35. C. Ukena, F. Mahfoud, and I. Kindermann Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension J Am Coll Cardiol 58 2011 1176 1182
36. E. Lambert, N. Straznicky, and M. Schlaich Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension Hypertension 50 2007 862 868
37. N.E. Straznicky, M.T. Grima, and N. Eikelis The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components J Clin Endocrinol Metab 96 2011 E503 E508
38. F. Mahfoud, M. Schlaich, and I. Kindermann Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study Circulation 123 2011 1940 1946
39. M.C. Brandt, F. Mahfoud, and S. Reda Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension J Am Coll Cardiol 59 2012 901 909
40. E. Pokushalov, A. Romanov, and G. Corbucci A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension J Am Coll Cardiol 60 2012 1163 1170
41. J.A. Staessen, Y. Jin, and L. Thijs First-in-man randomized clinical trial of renal denervation for atrial arrhythmia raises concern J Am Coll Cardiol 62 2013 e445 e446
42. J.E. Davies, C.H. Manisty, and R. Petraco First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study Int J Cardiol 162 2013 189 192
43. M.P. Schlaich, F. Socratous, and S. Hennebry Sympathetic activation in chronic renal failure J Am Soc Nephrol 20 2009 933 939
44. D. Hering, M.D. Esler, and M.P. Schlaich Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation Eurointervention 9 suppl 2013 R127 R135
45. D. Hering, F. Mahfoud, and A.S. Walton Renal denervation in moderate to severe CKD J Am Soc Nephrol 23 2012 1250 1257
46. F. Mahfoud, B. Cremers, and J. Janker Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension Hypertension 60 2012 419 424
47. R.L. Converse Jr., T.N. Jacobsen, and R.D. Toto Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 1992 1912 1918
48. M. Hausberg, M. Kosch, and P. Harmelink Sympathetic nerve activity in end-stage renal disease Circulation 106 2002 1974 1979
49. M.P. Schlaich, B. Bart, and D. Hering Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease Int J Cardiol 168 2013 2214 2220
50. J.R. Banegas, F.H. Messerli, and B. Waeber Discrepancies between office and ambulatory blood pressure: clinical implications Am J Med 122 2009 1136 1141
51. C. Ott, M.P. Schneider, and R.E. Schmieder Ruling out secondary causes of hypertension Eurointervention 9 suppl 2013 R21 R28
52. O. Jung, J.L. Gechter, and C. Wunder Resistant hypertension? Assessment of adherence by toxicological urine analysis J Hypertens 31 2013 766 774
53. W.L. Verloop, E.E. Vink, and M. Voskuil Eligibility for percutaneous renal denervation: the importance of a systematic screening J Hypertens 31 2013 1662 1668
54. F. Scolari, and P. Ravani Atheroembolic renal disease Lancet 375 2010 1650 1660
55. N. Chapman, J. Dobson, and S. Wilson Effect of spironolactone on blood pressure in subjects with resistant hypertension Hypertension 49 2007 839 845
56. M.K. Nishizaka, M.A. Zaman, and D.A. Calhoun Efficacy of low-dose spironolactone in subjects with resistant hypertension Am J Hypertens 16 2003 925 930
57. J. Vaclavik, R. Sedlak, and M. Plachy Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial Hypertension 57 2011 1069 1075
58. L.H. Cavallari, L.A. Fashingbauer, and A.L. Beitelshees Racial differences in patients' potassium concentrations during spironolactone therapy for heart failure Pharmacotherapy 24 2004 750 756
59. J.J. McMurray, and E. O'Meara Treatment of heart failure with spironolactone - trial and tribulations N Engl J Med 351 2004 526 528
60. D.N. Juurlink, M.M. Mamdani, and D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
61. G. Parati, G.S. Stergiou, and R. Asmar European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring J Hypertens 26 2008 1505 1526
62. J.M. Hansen, U. Abildgaard, and N. Fogh-Andersen The transplanted human kidney does not achieve functional reinnervation Clin Sci (Lond) 87 1994 13 20
63. M.J. Petersson, B. Rundqvist, and M. Johansson Increased cardiac sympathetic drive in renovascular hypertension J Hypertens 20 2002 1181 1187